Loading company details...
Latest Form 4 (Oct 17, 2026): Thomas Patrick Kelly (Chief Financial Officer): Exercise/Conversion of 7,500 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 17, 2026 | Thomas Patrick Kelly, Chief Financial Officer | Exercise/Conversion | 7,500 | n/a |
| Oct 1, 2026 | Thomas Patrick Kelly, Chief Financial Officer | Purchase | 15,000 | $559.7K |
| Oct 1, 2026 | Ian Mortimer, PRESIDENT & CEO | Purchase | 30,000 | $1.12M |
| Sep 4, 2026 | Dawn Svoronos | Exercise/Conversion | 5,144 | $41.9K |
| Sep 1, 2026 | Christopher John Kenney, Chief Medical Officer | Sale | 6,368 | $383.1K |
| Aug 13, 2026 | Steven Gannon | Sale | 10,000 | $640.6K |
| Jun 9, 2026 | Gary Patou | Sale | 1,322 | $70.3K |
| Jun 9, 2026 | Gillian Cannon | Sale | 1,190 | $63.2K |
| Jun 4, 2026 | Gary Patou | Exercise/Conversion | 2,645 | n/a |
| Jun 4, 2026 | Patrick Machado | Exercise/Conversion | 2,645 | n/a |